A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

SK Life Science

ClinicalTrials.gov Identifier:

NCT00740623

First received: August 21, 2008

Last updated: January 15, 2013

Last verified: January 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2010
Primary Completion Date:	October 2009 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	January 15, 2013